Base_name	Sample_name	Read_length	Sequencing_pool	Date_1st_submitted	Machine	Species	Strain_name	Genotype	Media	Comments	Group	Colection_time	25A	PolyIC	Triptolyde	CHX	Puromycin	Dataset	Inducer	TreatmentAK006M	AK4503_6	PE75	GL069	7/19/19	HiSeq3000	A549 human lung carinoma	A549	WT	RPMI with 10% FBS	"A549 wt, transfection Ctrl, 4.5 h"	Control	4.5h	-	-	-	-	-	one	None	NoneAK007M	AK007M	PE50	GL083	2/25/20	NovaSeq	A549 human lung carinoma	A549	RNaseL_KO	RPMI with 10% FBS	"A549 RNase L KO, transfection Ctrl, 4.5 h"	Control	4.5h	-	-	-	-	-	one	None	NoneAK008M	AK008M	PE50	GL083	2/25/20	NovaSeq	A549 human lung carinoma	A549	RNaseL_KO	RPMI with 10% FBS	"A549 RNase L KO, 1 然 trimer 2-5A. 4.5 h"	Treated	4.5h	+	-	-	-	-	one	25A	NoneAK010M	AK4503_10	PE75	GL069	7/19/19	HiSeq3000	A549 human lung carinoma	A549	WT	RPMI with 10% FBS	"A549 wt, 1 然 trimer 2-5A, 4.5 h"	Treated	4.5h	+	-	-	-	-	one	25A	NoneAK012M	AK4503_12	PE75	GL069	7/19/19	HiSeq3000	A549 human lung carinoma	A549	WT	RPMI with 10% FBS	"A549 wt, 0.25 痢/ml poly I:C, 4.5 h"	Treated	4.5h	-	+	-	-	-	one	polyIC	NoneAK014M	AK4773_14	PE75	GL072	10/4/19	HiSeq3000	A549 human lung carinoma	A549	WT	RPMI with 10% FBS	"A549 wt, transfection Ctrl, 4.5 h"	Control	4.5h	-	-	-	-	-	one	None	NoneAK016M	AK016M	PE50	GL083	2/25/20	NovaSeq	A549 human lung carinoma	A549	RNaseL_KO	RPMI with 10% FBS	"A549 RNase L KO, transfection Ctrl, 4.5 h (replicate)"	Control	4.5h	-	-	-	-	-	one	None	NoneAK017M	AK017M	PE50	GL083	2/25/20	NovaSeq	A549 human lung carinoma	A549	RNaseL_KO	RPMI with 10% FBS	"A549 RNase L KO, 1 然 trimer 2-5A. 4.5 h (replicate)"	Treated	4.5h	+	-	-	-	-	one	25A	NoneAK018M	AK4773_18	PE75	GL072	10/4/19	HiSeq3000	A549 human lung carinoma	A549	RNaseL_KO	RPMI with 10% FBS	"A549 RNase L KO, 0.25 痢/ml poly I:C, 4.5 h"	Treated	4.5h	-	+	-	-	-	one	polyIC	NoneAK021M	AK4773_21	PE75	GL072	10/4/19	HiSeq3000	A549 human lung carinoma	A549	WT	RPMI with 10% FBS	"A549 wt, 0.25 痢/ml poly I:C, 4.5 h"	Treated	4.5h	-	+	-	-	-	one	polyIC	NoneAK019M	AK4773_19	PE75	GL072	10/4/19	HiSeq3000	A549 human lung carinoma	A549	WT	RPMI with 10% FBS	"A549 wt, 1 然 trimer 2-5A, 4.5 h"	Treated	4.5h	+	-	-	-	-	one	25A	NoneAK029M	AK029M	PE50	GL083	2/25/20	NovaSeq	A549 human lung carinoma	A549	WT	RPMI with 10% FBS	" wt, 1 然 trimer 2-5A. 4.5 h"	Treated	4.5h	+	-	-	-	-	one	25A	NoneAK034M	AK034M	PE50	GL083	2/25/20	NovaSeq	A549 human lung carinoma	A549	RNaseL_KO	RPMI with 10% FBS	"A549 RNase L KO, 0.25 痢/ml poly I:C, 4.5 h (replicate)"	Treated	4.5h	-	+	-	-	-	one	polyIC	NoneAK013M	AK4503_13	PE75	GL069	7/19/19	HiSeq3000	A549 human lung carinoma	A549	WT	RPMI with 10% FBS	"A549 wt, 1 然 trimer 2-5A,, 2.25 h"	Treated	2.25h	+	-	-	-	-	two_cotreated	25A	NoneAK038M	AK5404_38	PE50	GL085	8/26/20	NovaSeq	A549 human lung carinoma	A549	WT	RPMI with 10% FBS	"1 然 trimer 2-5A, 2.25 h, co-treated, DMSO control"	Control	2.25h	+	-	-	-	-	two_cotreated	25A	NoneAK039M	AK5404_39	PE50	GL085	8/26/21	NovaSeq	A549 human lung carinoma	A549	WT	RPMI with 10% FBS	"1 然 trimer 2-5A, 2.25 h, co-treated, 1 然 triptolyde"	Treated	2.25h	+	-	+	-	-	two_cotreated	25A	NoneAK040M	AK5404_40	PE50	GL085	8/26/22	NovaSeq	A549 human lung carinoma	A549	WT	RPMI with 10% FBS	"1 然 trimer 2-5A, 2.25 h, co-treated, 1 然 triptolyde, 100 痢/ml CHX"	Treated	2.25h	+	-	+	+	-	two_cotreated	25A	Tripto+CHXAK041M	AK5404_41	PE50	GL085	8/26/23	NovaSeq	A549 human lung carinoma	A549	WT	RPMI with 10% FBS	"1 然 trimer 2-5A, 2.25 h, co-treated, 1 然 triptolyde, 100 痢/ml Puro"	Treated	2.25h	+	-	+	-	+	two_cotreated	25A	Tripto+PuroAK042M	AK5404_42	PE50	GL085	8/26/24	NovaSeq	A549 human lung carinoma	A549	WT	RPMI with 10% FBS	"1 然 trimer 2-5A, 2.25 h, co-treated, DMSO, 100 痢/ml CHX"	Treated	2.25h	+	-	-	+	-	two_cotreated	25A	CHXAK043M	AK5404_43	PE50	GL085	8/26/25	NovaSeq	A549 human lung carinoma	A549	WT	RPMI with 10% FBS	"1 然 trimer 2-5A, 2.25 h, co-treated, DMSO, 100 痢/ml Puro"	Treated	2.25h	+	-	-	-	+	two_cotreated	25A	PuroAK044M	AK5404_44	PE50	GL085	8/26/26	NovaSeq	A549 human lung carinoma	A549	WT	RPMI with 10% FBS	"1 然 trimer 2-5A, 4.5 h, co-treated, DMSO control"	Control	4.5h	+	-	-	-	-	two_cotreated	25A	NoneAK045M	AK5404_45	PE50	GL085	8/26/27	NovaSeq	A549 human lung carinoma	A549	WT	RPMI with 10% FBS	"1 然 trimer 2-5A, 4.5  h, co-treated, 1 然 triptolyde, 100 痢/ml Puro"	Treated	4.5h	+	-	+	-	-	two_cotreated	25A	TriptoAK046M	AK5404_46	PE50	GL085	8/26/28	NovaSeq	A549 human lung carinoma	A549	WT	RPMI with 10% FBS	"1 然 trimer 2-5A, 4.5  h, co-treated, 1 然 triptolyde, 100 痢/ml CHX"	Treated	4.5h	+	-	+	+	-	two_cotreated	25A	Tripto+CHXAK047M	AK5404_47	PE50	GL085	8/26/29	NovaSeq	A549 human lung carinoma	A549	WT	RPMI with 10% FBS	"1 然 trimer 2-5A, 4.5  h, co-treated, 1 然 triptolyde, 100 痢/ml Puro"	Treated	4.5h	+	-	+	-	+	two_cotreated	25A	Tripto+PuroAK048M	AK5404_48	PE50	GL085	8/26/30	NovaSeq	A549 human lung carinoma	A549	WT	RPMI with 10% FBS	"1 然 trimer 2-5A, 4.5 h, co-treated, DMSO, 100 痢/ml CHX"	Treated	4.5h	+	-	-	+	-	two_cotreated	25A	CHXAK049M	AK5404_49	PE50	GL085	8/26/31	NovaSeq	A549 human lung carinoma	A549	WT	RPMI with 10% FBS	"1 然 trimer 2-5A, 4.5 h, co-treated, DMSO, 100 痢/ml Puro"	Treated	4.5h	+	-	-	-	+	two_cotreated	25A	PuroAK050M	AK5404_50	PE50	GL085	8/26/32	NovaSeq	A549 human lung carinoma	A549	WT	RPMI with 10% FBS	"Lipofectamine, 4.5 h, DMSO control"	Control	4.5h	-	-	-	-	-	two_post_treated	None	NoneAK051M	AK5404_51	PE50	GL085	8/26/33	NovaSeq	A549 human lung carinoma	A549	WT	RPMI with 10% FBS	"0.25 mg/ml poly I:C, 2.25 h, co-treated, DMSO control"	Control	2.25h	-	+	-	-	-	two_cotreated	polyIC	NoneAK052M	AK5404_52	PE50	GL085	8/26/34	NovaSeq	A549 human lung carinoma	A549	WT	RPMI with 10% FBS	"0.25 mg/ml poly I:C, 2.25 h, co-treated, 1 然 triptolyde"	Treated	2.25h	-	+	+	-	-	two_cotreated	polyIC	NoneAK053M	AK5404_53	PE50	GL085	8/26/35	NovaSeq	A549 human lung carinoma	A549	WT	RPMI with 10% FBS	"0.25 mg/ml poly I:C, 2.25 h, co-treated, 1 然 triptolyde, 100 痢/ml Puro"	Treated	2.25h	-	+	+	-	+	two_cotreated	polyIC	Tripto+PuroAK054M	AK5404_54	PE50	GL085	8/26/36	NovaSeq	A549 human lung carinoma	A549	WT	RPMI with 10% FBS	"0.25 mg/ml poly I:C, 2.25 h, co-treated, DMSO, 100 痢/ml Puro"	Treated	2.25h	-	+	-	-	+	two_cotreated	polyIC	PuroAK055M	AK5404_55	PE50	GL085	8/26/37	NovaSeq	A549 human lung carinoma	A549	WT	RPMI with 10% FBS	"0.25 mg/ml poly I:C, 4.5 h, co-treated, DMSO control"	Control	4.5h	-	+	-	-	-	two_cotreated	polyIC	NoneAK056M	AK5404_56	PE50	GL085	8/26/38	NovaSeq	A549 human lung carinoma	A549	WT	RPMI with 10% FBS	"0.25 mg/ml poly I:C, 4.5 h, co-treated, 1 然 triptolyde"	Treated	4.5h	-	+	+	-	-	two_cotreated	polyIC	NoneAK057M	AK5404_57	PE50	GL085	8/26/39	NovaSeq	A549 human lung carinoma	A549	WT	RPMI with 10% FBS	"0.25 mg/ml poly I:C, 4.5 h, co-treated, 1 然 triptolyde, 100 痢/ml Puro"	Treated	4.5h	-	+	+	-	+	two_cotreated	polyIC	Tripto+PuroAK058M	AK5404_58	PE50	GL085	8/26/40	NovaSeq	A549 human lung carinoma	A549	WT	RPMI with 10% FBS	"0.25 mg/ml poly I:C, 4.5 h, co-treated, DMSO, 100 痢/ml Puro"	Treated	4.5h	-	+	-	-	+	two_cotreated	polyIC	PuroAK059M	AK5404_59	PE50	GL085	8/26/41	NovaSeq	A549 human lung carinoma	A549	WT	RPMI with 10% FBS	"1 然 trimer 2-5A, 4.5 h, treated at 2.25 h, DMSO control"	Control	4.5h	+	-	-	-	-	two_post_treated	25A	NoneAK060M	AK5404_60	PE50	GL085	8/26/42	NovaSeq	A549 human lung carinoma	A549	WT	RPMI with 10% FBS	"1 然 trimer 2-5A, 4.5 h, treated at 2.25 h, 1 然 triptolyde"	Treated	4.5h	+	-	+	-	-	two_post_treated	25A	NoneAK061M	AK5404_61	PE50	GL085	8/26/43	NovaSeq	A549 human lung carinoma	A549	WT	RPMI with 10% FBS	"1 然 trimer 2-5A, 4.5 h, treated at 2.25 h, 1 然 triptolyde, 100 痢/ml Puro"	Treated	4.5h	+	-	+	-	+	two_post_treated	25A	Tripto+PuroAK062M	AK5404_62	PE50	GL085	8/26/44	NovaSeq	A549 human lung carinoma	A549	WT	RPMI with 10% FBS	"1 然 trimer 2-5A, 4.5 h, treated at 2.25 h, DMSO, 100 痢/ml Puro"	Treated	4.5h	+	-	-	-	+	two_post_treated	25A	PuroAK063M	AK5404_63	PE50	GL085	8/26/45	NovaSeq	A549 human lung carinoma	A549	WT	RPMI with 10% FBS	"0.25 mg/ml poly I:C, 4.5 h, treated at 2.25 h, DMSO control"	Control	4.5h	-	+	-	-	-	two_post_treated	polyIC	NoneAK064M	AK5404_64	PE50	GL085	8/26/46	NovaSeq	A549 human lung carinoma	A549	WT	RPMI with 10% FBS	"0.25 mg/ml poly I:C, 4.5 h, treated at 2.25 h, 1 然 triptolyde"	Treated	4.5h	-	+	+	-	-	two_post_treated	polyIC	NoneAK065M	AK5404_65	PE50	GL085	8/26/47	NovaSeq	A549 human lung carinoma	A549	WT	RPMI with 10% FBS	"0.25 mg/ml poly I:C, 4.5 h, treated at 2.25 h, 1 然 triptolyde, 100 痢/ml Puro"	Treated	4.5h	-	+	+	-	+	two_post_treated	polyIC	Tripto+PuroAK066M	AK5404_66	PE50	GL085	8/26/48	NovaSeq	A549 human lung carinoma	A549	WT	RPMI with 10% FBS	"0.25 mg/ml poly I:C, 4.5 h, treated at 2.25 h, DMSO, 100 痢/ml Puro"	Treated	4.5h	-	+	-	-	+	two_post_treated	polyIC	PuroAK070M	AK5590_1	PE50	GL89	12/7/20	NovaSeq	A549 human lung carinoma	A549	WT	RPMI with 10% FBS	Lipofectamin treated	Control	4.5h	-	-	-	-	-	two_cotreated	None	NoneAK071M	AK5590_2	PE50	GL89	12/8/20	NovaSeq	A549 human lung carinoma	A549	WT	RPMI with 10% FBS	Lipofectamine + 1 然 Triptolyde treated	Treated	4.5h	-	-	+	-	-	two_cotreated	None	NoneAK072M	AK5590_3	PE50	GL89	12/9/20	NovaSeq	A549 human lung carinoma	A549	WT	RPMI with 10% FBS	Lipofectamine + 1 然 Triptolyde + 100 痢/ml CHX  treated	Treated	4.5h	-	-	+	+	-	two_cotreated	None	Tripto+CHXAK073M	AK5590_4	PE50	GL89	12/10/20	NovaSeq	A549 human lung carinoma	A549	WT	RPMI with 10% FBS	Lipofectamine + 1 然 Triptolyde + 100 痢/ml Puro  treated	Treated	4.5h	-	-	+	-	+	two_cotreated	None	Tripto+PuroAK074M	AK5590_5	PE50	GL89	12/11/20	NovaSeq	A549 human lung carinoma	A549	WT	RPMI with 10% FBS	Lipofectamine + 100 痢/ml CHX  treated	Treated	4.5h	-	-	-	+	-	two_cotreated	None	CHXAK075M	AK5590_6	PE50	GL89	12/12/20	NovaSeq	A549 human lung carinoma	A549	WT	RPMI with 10% FBS	Lipofectamine + 100 痢/ml Puro  treated	Treated	4.5h	-	-	-	-	+	two_cotreated	None	Puro